{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T20:57:07Z","timestamp":1770325027495,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["SAL2006\/0275"],"award-info":[{"award-number":["SAL2006\/0275"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003381","name":"Minist\u00e9rio da Educa\u00e7\u00e3o e Ci\u00eancia","doi-asserted-by":"publisher","award":["SAF2006-0854"],"award-info":[{"award-number":["SAF2006-0854"]}],"id":[{"id":"10.13039\/501100003381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RETICS-RD06\/0026"],"award-info":[{"award-number":["RETICS-RD06\/0026"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud y Familias, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.expneurol.2008.03.008","type":"journal-article","created":{"date-parts":[[2008,3,26]],"date-time":"2008-03-26T09:34:07Z","timestamp":1206524047000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: Implication of ERK1\/2 and PPAR\u03b3 receptors"],"prefix":"10.1016","volume":"212","author":[{"given":"Angelo O.","family":"Rosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Egea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio G.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela G.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2008.03.008_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.expneurol.2008.03.008_bib2","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1073\/pnas.190297597","article-title":"Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration","volume":"97","author":"Bhat","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2008.03.008_bib3","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418","volume":"278","author":"Bhat","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(01)02310-2","article-title":"An investigation of the neuroprotective effect of lithium in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation","volume":"315","author":"Cimarosti","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2008.03.008_bib5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4049\/jimmunol.161.2.978","article-title":"Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1","volume":"161","author":"Colville-Nash","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2008.03.008_bib6","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1471-4159.2007.04665.x","article-title":"Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress","volume":"102","author":"Egea","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.neuroscience.2006.12.036","article-title":"Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice","volume":"145","author":"Egea","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.03.008_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","article-title":"Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase","volume":"107","author":"Embi","year":"1980","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/00001756-200308060-00012","article-title":"Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity","volume":"14","author":"Facci","year":"2003","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2008.03.008_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00000542-200511000-00013","article-title":"Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta","volume":"103","author":"Feng","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.expneurol.2008.03.008_bib11","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00018-007-7045-7","article-title":"Glycogen synthase kinase 3: a key regulator of cellular fate","volume":"64","author":"Forde","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2008.03.008_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3590001","article-title":"GSK3 takes centre stage more than 20\u00a0years after its discovery","volume":"359","author":"Frame","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2008.03.008_bib13","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1124\/mol.105.012260","article-title":"Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling","volume":"68","author":"Gardner","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.expneurol.2008.03.008_bib14","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.1074\/jbc.M410445200","article-title":"Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium\/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress","volume":"280","author":"Gardner","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1432-1033.1981.tb05628.x","article-title":"Purification of glycogen synthase kinase 3 from rabbit skeletal muscle. Copurification with the activating factor (FA) of the (Mg-ATP) dependent protein phosphatase","volume":"119","author":"Hemmings","year":"1981","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib16","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/1389450110607011421","article-title":"Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions","volume":"7","author":"Jope","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.expneurol.2008.03.008_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.expneurol.2004.04.004","article-title":"Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia","volume":"188","author":"Kelly","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.03.008_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2007.10.018","article-title":"Inhibition of GSK-3b mediates expression of MMP-9 through ERK1\/2 activation and traslocation of NF-kB in rat primary astrocyte","volume":"1186","author":"Kim","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.03.008_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1385\/JMN:24:2:237","article-title":"Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha","volume":"24","author":"Kirshenboim","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2008.03.008_bib20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.tox.2005.08.015","article-title":"15-Deoxy-delta12,14-prostaglandin J2, a neuroprotectant or a neurotoxicant?","volume":"216","author":"Koh","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.expneurol.2008.03.008_bib21","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1749-6632.1996.tb18619.x","article-title":"PPAR tissue distribution and interactions with other hormone-signaling pathways","volume":"804","author":"Lemberger","year":"1996","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2008.03.008_bib23","doi-asserted-by":"crossref","first-page":"29681","DOI":"10.1074\/jbc.M201517200","volume":"277","author":"Lennon","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0891-0618(99)00012-5","article-title":"Developmental expression and localization of glycogen synthase kinase-3beta in rat brain","volume":"16","author":"Leroy","year":"1999","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.expneurol.2008.03.008_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.ATV.0000201933.53964.5b","article-title":"15d-prostaglandin J2 protects brain from ischemia\u2013reperfusion injury","volume":"26","author":"Lin","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.expneurol.2008.03.008_bib26","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.M414390200","article-title":"Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation","volume":"280","author":"Luna-Medina","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib27","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1523\/JNEUROSCI.1004-07.2007","article-title":"NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders","volume":"27","author":"Luna-Medina","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.03.008_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1471-4159.2006.03758.x","article-title":"Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone","volume":"97","author":"Luo","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib29","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0006-3223(99)00165-1","article-title":"Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?","volume":"46","author":"Manji","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2008.03.008_bib30","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/jm011020u","article-title":"First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease","volume":"45","author":"Martinez","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/med.10011","article-title":"Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation","volume":"22","author":"Martinez","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.expneurol.2008.03.008_bib32","doi-asserted-by":"crossref","first-page":"35715","DOI":"10.1074\/jbc.M006577200","article-title":"Peroxisome proliferator-activated receptors and hepatic stellate cell activation","volume":"275","author":"Miyahara","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib33","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1097\/00001756-199806220-00031","article-title":"Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats","volume":"9","author":"Nonaka","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2008.03.008_bib34","series-title":"Synthesis of 1,2,4-Thiadiazolidine-3,5-diones","first-page":"672","article-title":"Chlorination of isothiocyanates. III. N-aryl and N-alkyl-S-chloroisothio-carbamoyl chlorides with isocyanates","volume":"vol. 5","author":"Ottman","year":"1966"},{"key":"10.1016\/j.expneurol.2008.03.008_bib35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1517\/14728222.11.8.1071","article-title":"The non-genomic crosstalk between PPAR-gamma ligands and ERK1\/2 in cancer cell lines","volume":"11","author":"Papageorgiou","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.expneurol.2008.03.008_bib36","doi-asserted-by":"crossref","first-page":"19929","DOI":"10.1074\/jbc.273.32.19929","article-title":"Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase\/Akt cell survival pathway","volume":"273","author":"Pap","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib37","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.106.113472","article-title":"Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats","volume":"320","author":"Park","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2008.03.008_bib38","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.jnen.0000178852.83680.3c","article-title":"The nonthiazolidinedione PPARgamma agonist L-796,449 is neuroprotective in experimental stroke","volume":"64","author":"Pereira","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.03.008_bib39","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1073\/pnas.96.8.4668","article-title":"Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2","volume":"96","author":"Petrova","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2008.03.008_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2008.03.008_bib41","doi-asserted-by":"crossref","first-page":"13452","DOI":"10.1074\/jbc.272.20.13452","article-title":"Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells","volume":"272","author":"Rokos","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1432-1033.1980.tb06060.x","article-title":"Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal sequence containing the site phosphorylated by phosphorylase kinase","volume":"107","author":"Rylatt","year":"1980","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuint.2006.03.020","article-title":"PPARgamma as a therapeutic target in central nervous system diseases","volume":"49","author":"Sundararajan","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2008.03.008_bib44","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1021\/bi035627j","article-title":"Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing","volume":"43","author":"Su","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2008.03.008_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(01)03242-5","article-title":"Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons","volume":"924","author":"Uryu","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.03.008_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(98)10364-1","article-title":"Medical significance of peroxisome proliferator-activated receptors","volume":"354","author":"Vamecq","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2008.03.008_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1745-7254.2006.00259.x","article-title":"Neuroprotective effects of stearic acid against toxicity of oxygen\/glucose deprivation or glutamate on rat cortical or hippocampal slices","volume":"27","author":"Wang","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.expneurol.2008.03.008_bib48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2008.03.008_bib49","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/j.1460-2075.1990.tb07419.x","article-title":"Molecular cloning and expression of glycogen synthase kinase-3\/factor A","volume":"9","author":"Woodgett","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2008.03.008_bib50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2007.06.092","article-title":"Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons","volume":"1172","author":"Zhao","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.03.008_bib51","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.brainres.2005.12.061","article-title":"Peroxisome-proliferator-activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity","volume":"1073\u20131074","author":"Zhao","year":"2006","journal-title":"Brain Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:42:47Z","timestamp":1762148567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488608001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0014488608001118"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2008.03.008","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: Implication of ERK1\/2 and PPAR\u03b3 receptors","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2008.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}